文献速递急性肾损伤

抑制丙酮酸脱氢酶激酶4通过减少缺血期琥珀酸蓄积并保护再灌注期线粒体功能改善肾缺血再灌注损伤

Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion.
PubMed 文献 · Kidney Int · 2023-07-01

该研究利用近端小管细胞特异性Pdk4敲除小鼠及药理学抑制,探讨丙酮酸脱氢酶激酶4(PDK4)在缺血再灌注(IR)诱导的急性肾损伤中的作用。结果显示,敲除或药理学抑制PDK4可减轻IR诱导的肾损伤,减少缺血期琥珀酸蓄积,并保护线粒体功能;外源性琥珀酸可削弱该保护效应,提示其作用依赖琥珀酸。作者认为抑制PDK4是预防IR诱导肾损伤的新方法。

要点

  • 近端小管细胞特异性敲除或药理学抑制PDK4可减轻小鼠缺血再灌注诱导的肾损伤。
  • PDK4抑制减少缺血期琥珀酸蓄积,并保护再灌注期线粒体功能。
  • 外源性二甲基琥珀酸削弱PDK4缺失的保护效应,提示该保护作用依赖琥珀酸。

核心结论

  • 抑制PDK4通过减少缺血期琥珀酸蓄积和线粒体功能障碍来抑制活性氧诱导的肾毒性,是预防IR诱导肾损伤的新方法。

研究设计与样本

  • 使用近端小管细胞特异性Pdk4敲除(Pdk4ptKO)小鼠,并采用药理学抑制PDK4,在体内IR损伤模型及体外IR损伤模型中观察作用。

主要发现

  • 敲除或药理学抑制PDK4可改善IR诱导的肾损伤。
  • PDK4抑制减少了缺血期琥珀酸蓄积,该蓄积是再灌注期线粒体活性氧产生的原因。
  • PDK4缺失在缺血前建立的条件导致较少的琥珀酸蓄积,可能因为复合体II中电子流反向减少,而该反向电子流在缺血期间为琥珀酸脱氢酶将延胡索酸还原为琥珀酸提供电子。
  • 给予二甲基琥珀酸(一种细胞可渗透的琥珀酸形式)减弱了PDK4缺失的有益效应,提示肾脏保护效应依赖琥珀酸。
  • 遗传或药理学抑制PDK4可预防小鼠IR诱导的线粒体损伤,并在体外IR损伤模型中使线粒体功能正常化。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ischemia-reperfusion (IR) injury, a leading cause of acute kidney injury (AKI), is still without effective therapies. Succinate accumulation during ischemia followed by its oxidation during reperfusion leads to excessive reactive oxygen species (ROS) and severe kidney damage. Consequently, the targeting of succinate accumulation may represent a rational approach to the prevention of IR-induced kidney injury. Since ROS are generated primarily in mitochondria, which are abundant in the proximal tubule of the kidney, we explored the role of pyruvate dehydrogenase kinase 4 (PDK4), a mitochondrial enzyme, in IR-induced kidney injury using proximal tubule cell-specific Pdk4 knockout (Pdk4ptKO) mice. Knockout or pharmacological inhibition of PDK4 ameliorated IR-induced kidney damage. Succinate accumulation during ischemia, which is responsible for mitochondrial ROS production during reperfusion, was reduced by PDK4 inhibition. PDK4 deficiency established conditions prior to ischemia resulting in less succinate accumulation, possibly because of a reduction in electron flow reversal in complex II, which provides electrons for the reduction of fumarate to succinate by succinate dehydrogenase during ischemia. The administration of dimethyl succinate, a cell-permeable form of succinate, attenuated the beneficial effects of PDK4 deficiency, suggesting that the kidney-protective effect is succinate-dependent. Finally, genetic or pharmacological inhibition of PDK4 prevented IR-induced mitochondrial damage in mice and normalized mitochondrial function in an in vitro model of IR injury. Thus, inhibition of PDK4 represents a novel means of preventing IR-induced kidney injury, and involves the inhibition of ROS-induced kidney toxicity through reduction in succinate accumulation and mitochondrial dysfunction.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Oh CJ, Kim MJ, Lee JM, et al. Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion. Kidney Int. 2023. PMID: 37399974. doi:10.1016/j.kint.2023.06.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。